PYC Therapeutics Ltd

PYC

Company Profile

  • Business description

    PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company’s drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.

  • Contact

    6 Verdun Street
    Harry Perkins Institute of Medical Research
    Nedlands
    PerthWA6009
    AUS

    T: +61 861510992

    https://www.pyctx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    5

Stocks News & Analysis

stocks

Nvidia: Collaboration with Intel might bring some goodwill with the US

We doubt the $5 billion is meaningful enough to force Nvidia to use Intel, either for core products or even for the chips in collaboration.
stocks

What now for Santos after takeover offer collapses?

Our Fair Value estimate once again reflects the stand-alone business and its growth potential.
stocks

Morningstar initiates coverage on small cap ASX REIT

Coverage of ASX listed REIT as investor interest in property continues to grow.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,061.2061.30-0.67%
CAC 407,853.591.02-0.01%
DAX 4023,639.4135.12-0.15%
Dow JONES (US)46,315.27172.850.37%
FTSE 1009,216.6711.44-0.12%
HKSE26,545.10106.590.40%
NASDAQ22,631.48160.750.72%
Nikkei 22545,045.81143.540.32%
NZX 50 Index13,231.663.23-0.02%
S&P 5006,664.3632.400.49%
S&P/ASX 2008,773.5075.00-0.85%
SSE Composite Index3,820.0911.57-0.30%

Market Movers